150 related articles for article (PubMed ID: 20045986)
1. Biotransformation profiling of [(14)C]ixabepilone in human plasma, urine and feces samples using accelerator mass spectrometry (AMS).
Cömezoğlu SN; Ly VT; Zhang D; Humphreys WG; Bonacorsi SJ; Everett DW; Cohen MB; Gan J; Beumer JH; Beijnen JH; Schellens HM; Lappin G
Drug Metab Pharmacokinet; 2009; 24(6):511-22. PubMed ID: 20045986
[TBL] [Abstract][Full Text] [Related]
2. Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry.
Beumer JH; Garner RC; Cohen MB; Galbraith S; Duncan GF; Griffin T; Beijnen JH; Schellens JH
Invest New Drugs; 2007 Aug; 25(4):327-34. PubMed ID: 17347871
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of [
Pusalkar S; Plesescu M; Gupta N; Hanley M; Venkatakrishnan K; Wu JT; Xia C; Zhang X; Chowdhury S
Cancer Chemother Pharmacol; 2018 Nov; 82(5):803-814. PubMed ID: 30128949
[TBL] [Abstract][Full Text] [Related]
4. Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry.
Tse S; Leung L; Raje S; Seymour M; Shishikura Y; Obach RS
Drug Metab Dispos; 2014 Dec; 42(12):2023-32. PubMed ID: 25217486
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the absorption, metabolism and excretion of [¹⁴C]pasireotide in healthy volunteers using accelerator mass spectrometry.
Lin TH; Hu K; Flarakos J; Sharr-McMahon M; Mangold JB; He H; Wang Y
Cancer Chemother Pharmacol; 2013 Jul; 72(1):181-8. PubMed ID: 23680921
[TBL] [Abstract][Full Text] [Related]
6. Application of liquid chromatography-accelerator mass spectrometry (LC-AMS) to evaluate the metabolic profiles of a drug candidate in human urine and plasma.
Prakash C; Shaffer CL; Tremaine LM; Liberman RG; Skipper PL; Flarakos J; Tannenbaum SR
Drug Metab Lett; 2007 Aug; 1(3):226-31. PubMed ID: 19356047
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor.
Garner RC; Goris I; Laenen AA; Vanhoutte E; Meuldermans W; Gregory S; Garner JV; Leong D; Whattam M; Calam A; Snel CA
Drug Metab Dispos; 2002 Jul; 30(7):823-30. PubMed ID: 12065441
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P
Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Disposition, and Biotransformation of [
Weber E; Subramanian R; Rowe W; Graupe M; Ling J; Shen G; Begley R; Sager J; Wolckenhauer S; Rhee M; Palaparthy R; Singh R
Clin Pharmacokinet; 2024 Feb; 63(2):241-253. PubMed ID: 38236562
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of [
Mancel V; Mathy FX; Boulanger P; English S; Croft M; Kenney C; Knott T; Stockis A; Bani M
Xenobiotica; 2017 Aug; 47(8):705-718. PubMed ID: 27489076
[TBL] [Abstract][Full Text] [Related]
11. Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects.
Gerisch M; Hafner FT; Lang D; Radtke M; Diefenbach K; Cleton A; Lettieri J
Cancer Chemother Pharmacol; 2018 Jan; 81(1):195-206. PubMed ID: 29188322
[TBL] [Abstract][Full Text] [Related]
12. A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts.
Garner RC; Barker J; Flavell C; Garner JV; Whattam M; Young GC; Cussans N; Jezequel S; Leong D
J Pharm Biomed Anal; 2000 Dec; 24(2):197-209. PubMed ID: 11130199
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra) in human plasma: method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degradants.
Xu XS; Zeng J; Mylott W; Arnold M; Waltrip J; Iacono L; Mariannino T; Stouffer B
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(5-6):525-37. PubMed ID: 20083444
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [
Yang Z; Wong SL; Cha D; Wilfret D; Turnquist D; Plummer A; van Ingen E; Kearney BP
Drug Metab Dispos; 2023 Dec; 51(12):1607-1614. PubMed ID: 37684056
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients.
Slatter JG; Schaaf LJ; Sams JP; Feenstra KL; Johnson MG; Bombardt PA; Cathcart KS; Verburg MT; Pearson LK; Compton LD; Miller LL; Baker DS; Pesheck CV; Lord RS
Drug Metab Dispos; 2000 Apr; 28(4):423-33. PubMed ID: 10725311
[TBL] [Abstract][Full Text] [Related]
16. Mass balance and metabolism of the antimalarial pyronaridine in healthy volunteers.
Morris CA; Dueker SR; Lohstroh PN; Wang LQ; Fang XP; Jung D; Lopez-Lazaro L; Baker M; Duparc S; Borghini-Fuhrer I; Pokorny R; Shin JS; Fleckenstein L
Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):75-86. PubMed ID: 24590312
[TBL] [Abstract][Full Text] [Related]
17. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disposition of [14C]bazedoxifene in healthy postmenopausal women.
Chandrasekaran A; McKeand WE; Sullivan P; DeMaio W; Stoltz R; Scatina J
Drug Metab Dispos; 2009 Jun; 37(6):1219-25. PubMed ID: 19273530
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of an oral taxane analog, [14C]3'-tert-butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxy-paclitaxel (BMS-275183), in rats and dogs.
Ly VT; Caceres-Cortes J; Zhang D; Humphreys WG; Ekhato IV; Everett D; Cömezoğlu SN
Drug Metab Dispos; 2009 May; 37(5):1115-28. PubMed ID: 19196843
[TBL] [Abstract][Full Text] [Related]
20. Disposition and biotransformation of the antipsychotic agent olanzapine in humans.
Kassahun K; Mattiuz E; Nyhart E; Obermeyer B; Gillespie T; Murphy A; Goodwin RM; Tupper D; Callaghan JT; Lemberger L
Drug Metab Dispos; 1997 Jan; 25(1):81-93. PubMed ID: 9010634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
